FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Hold on Allogene CAR T Trial Over Chromosomal Abnormality

[ Price : $8.95]

FDA places a clinical hold on Allogene Therapeutics clinical trials involving Allo-501A CAR T cells after a report of a chromosom...

Pfizer Seeks Covid Vaccine EUA for Children 5-12

[ Price : $8.95]

Pfizer and BioNTech say they have formally submitted an emergency use authorization request for their mRNA Covid-19 vaccine and it...

Hospital, Health System Drug Compounding Guidance

[ Price : $8.95]

FDA issues a revised draft guidance on drug compounding by hospital and health system pharmacies.

Polarean Imaging Complete Response Letter

[ Price : $8.95]

FDA raises issues to be resolved in a complete response letter to a Polarean Imaging NDA for a drug-combination product to enhance...

Guide on Real-world Data for Animal Drug

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled #266 Use of Real-World Data and Real-World Evidence to Supp...

Guide on Foreign Studies for Animal Drugs

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled #265 Use of Data from Foreign Investigational Studies to Su...

Cassava Sciences Opens Phase 3 Alzheimers Trial

[ Price : $8.95]

Cassava Sciences says it is opening its first of two Phase 3 efficacy studies of simufilam for use in patients with mild to modera...

FDA Benefit/Risk Guidance Analyzed

[ Price : $8.95]

Fagere Drinker consultants analyze a new FDA draft guidance on how the agency handles benefit/risk assessment for drug and biologi...

Acer NDA for Urea Cycle Disorders

[ Price : $8.95]

FDA accepts for review an Acer Therapeutics NDA for Acer-001 sodium phenylbutyrate) for treating patients with urea cycle disorder...

FDA Fetal Pharmacology and Therapeutics Workshop

[ Price : $8.95]

FDA announces a 10/21-10/22 virtual workshop on fetal pharmacology and therapeutics.